Non-Current Assets
Investments
Eli Lilly Investments increased by 11.2% to $3.12B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 3.3%, from $3.22B to $3.12B. Over 5 years (FY 2020 to FY 2025), Investments shows relatively stable performance with a -1.1% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Assets
CategoryCapital Allocation
SignalHigher is better
VolatilityStable
First reportedQ4 2014
Last reportedQ1 2026Apr 30, 2026
How to read this metric
Growth in this area suggests the company is deploying excess capital into long-term wealth-generating assets.
Detailed definition
These are investments in securities, joint ventures, or other long-term financial assets that the company intends to hol...
Peer comparison
Common in large, diversified healthcare firms that manage significant investment portfolios.
Metric ID:
non_current_assets_long_term_investmentsHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $3.47B | $3.35B | $3.21B | $2.73B | $2.59B | $2.57B | $2.90B | $2.75B | $2.75B | $2.69B | $3.05B | $3.09B | $2.88B | $3.20B | $3.22B | $3.22B | $3.21B | $2.81B | $2.80B | $3.12B |
| QoQ Change | — | -3.6% | -4.1% | -15.1% | -5.1% | -0.5% | +12.7% | -5.2% | -0.2% | -1.9% | +13.4% | +1.1% | -6.8% | +11.2% | +0.5% | +0.2% | -0.5% | -12.4% | -0.2% | +11.2% |
| YoY Change | — | — | — | — | -25.5% | -23.2% | -9.7% | +0.8% | +6.1% | +4.5% | +5.2% | +12.2% | +4.8% | +18.9% | +5.4% | +4.4% | +11.5% | -12.2% | -12.9% | -3.3% |
Range$2.57B – $3.47B
CAGR-2.3%
Avg YoY Growth-0.8%
Median YoY Growth+4.5%
Investments at Other Companies
Frequently Asked Questions
- What is Eli Lilly's investments?
- Eli Lilly (LLY) reported investments of $3.12B in Q1 2026.
- How has Eli Lilly's investments changed year-over-year?
- Eli Lilly's investments decreased by 3.3% year-over-year, from $3.22B to $3.12B.
- What is the long-term trend for Eli Lilly's investments?
- Over 5 years (2020 to 2025), Eli Lilly's investments has grown at a -1.1% compound annual growth rate (CAGR), from $2.97B to $2.80B.
- What does investments mean?
- Long-term financial investments held by the company for strategic or yield purposes.